Malek Tabbara

Malek Tabbara

Auto-generated profile, based on publicly available information

Malek Tabbara

Paris XIII University-University Hospitals of Paris Seine Saint-Denis

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2009 in Archives of Surgery
Verified
Journal Article
Open access
PDF file
ESElizabeth A. Sailhamer
Elizabeth A. Sailhamer
KCKatherine Carson
Katherine Carson
YCYuchiao Chang
Yuchiao Chang
NZNikolaos Zacharias
Nikolaos Zacharias
KSKonstantinos Spaniolas
Konstantinos Spaniolas
GVGeorge C. Velmahos
George C. Velmahos
Clostridium difficile colitis is the most common nosocomial infection of the gastrointestinal tract, affecting more than 3 million patients per year in the United States, and is associated with significant morbidity and mortality.1-3Clostridium difficile is an anaerobic, spore-forming, gram-positive bacillus that in pathogenic strains produces 2 important exotoxins that cause diarrhea and colitis. When established in the colon, it causes a spectrum of disease severity, ranging from asymptomatic carriage to severe diarrhea, pseudomembranous colitis, toxic megacolon, colonic perforation, or death. Fulminant C difficile colitis has been broadly defined as C difficile colitis with significant systemic toxic effects and shock, resulting in need for colectomy or death, and occurs in approximately 3% to 5% of patients with C difficile colitis, with a marked increase in severity and mortality during the last several years.4-6 The objectives of this study are to analyze characteristics of and treatment patterns in patients with fulminant C difficile colitis and to identify predictors of mortality.

1 October 2009 in Archives of Surgery
Verified
Journal Article
Open access
PDF file
GVGeorge C. Velmahos
George C. Velmahos
KSKonstantinos Spaniolas
Konstantinos Spaniolas
MTMalek Tabbara
Malek Tabbara
HAHani H. Abujudeh
Hani H. Abujudeh
MMMarc de Moya
Marc de Moya
HAHasan B. Alam
Hasan B. Alam
For decades, it has been taught that pulmonary embolism (PE) is a sequel of deep venous thrombosis (DVT).1,2 Forming in the lower extremity or pelvic veins, clots break off and travel to the pulmonary circulation. Therefore, DVT and PE should coexist in most patients, because part of the clot embolizes in the lung, and part remains attached to the vein. However, this has not been confirmed in practice. In a study3 of 149 patients with PE, less than one-third had positive DVT symptoms when evaluated by compression ultrasonography. Serial and detailed imaging of leg veins identified DVT in only 43% of 169 patients with PE.4 Among 131 trauma patients, 18 developed DVT or PE, but only 6 of 18 showed evidence of both.5 None of 4 trauma patients with PE among 12 with thromboembolic events showed evidence of DVT.6 Of 52 high-risk trauma patients, 12 developed DVT, and 2 developed PE (neither had DVT).7 Similarly, among 200 prospectively screened high-risk trauma patients, 26 developed DVT, and 4 developed PE. There was no progression to PE among the patients with DVT, and none of the patients with PE had DVT.8 Ultrasonography was used for DVT diagnosis in all of these studies. Limitations of this technique resulted in the failure to identify expected DVT. Ultrasonographic findings are operator dependent and may be inaccurate below the knee and (most important) in the pelvis.

1 November 2008 in Journal of Trauma: Injury, Infection & Critical Care
Verified
Journal Article
Closed access
FSFahad Shuja
Fahad Shuja
CSChristian Shults
Christian Shults
MDMichael Duggan
Michael Duggan
MTMalek Tabbara
Malek Tabbara
MBMuhammad U. Butt
Muhammad U. Butt
HAHasan B. Alam
Hasan B. Alam
Trauma-induced coagulopathy is associated with an extremely high mortality. We have recently shown that survival can be improved by correction of coagulopathy through early, aggressive infusion of Fresh Frozen Plasma (FFP). However, FFP is a perishable product, and its use is impractical in challenging environments such as a battlefield. Development of shelf-stable, easy to use, low volume, lyophilized, Freeze-Dried Plasma (FDP) can overcome the logistical limitations. We hereby report the development and testing of such a product. Plasma separated from fresh porcine blood (n = 10) was either stored as FFP, or lyophilized to produce the FDP. For in vitro testing, the FDP was rehydrated with distilled water and the pH, temperature, and osmolarity were adjusted to match the thawed FFP. Laboratory analysis included measurements of prothrombin time (PT), partial thromboplastin time, fibrinogen levels, and clotting factors II, VII, and IX. To test in vivo efficacy, swine were subjected to multiple injuries (femur fracture and grade V liver injury) and severe hemorrhagic shock (60% blood loss associated with "lethal triad" of coagulopathy, acidosis, and hypothermia), and resuscitated with FFP or FDP (n = 6/group; plasma volumes equal to the volume of shed blood). No treatment, and resuscitation with fresh whole blood served as the control groups (n = 6/group). Coagulation profiles (thromboelastography, PT, partial thromboplastin time, international normalized ratio, fibrinogen) were measured serially during the experiment, and for 4 hours posttreatment. In vitro analysis revealed no differences in the coagulation profiles of FFP and FDP. The lyophilization process did not decrease the activity levels of the measured clotting factors. In the swine model, multiple injuries and hemorrhagic shock caused a 50% to 70% increase in PT (p = 0.03), and infusion of FDP and FFP were equally effective in correcting the coagulopathy. Plasma can be lyophilized and freeze-dried to create a logistically superior product without compromising its hemostatic properties. This product may be suitable for use in austere environments, such as a battlefield, for the treatment of trauma-associated coagulopathy.

1 March 2009 in Journal of Trauma: Injury, Infection & Critical Care
Verified
Journal Article
Closed access
HPHerb A. Phelan
Herb A. Phelan
GVGeorge C. Velmahos
George C. Velmahos
GJGregory J. Jurkovich
Gregory J. Jurkovich
RFRandall S. Friese
Randall S. Friese
JMJoseph P. Minei
Joseph P. Minei
CCC Clay Cothren
C Clay Cothren
Efforts to determine the suitability of low-grade pancreatic injuries for nonoperative management have been hindered by the inaccuracy of older computed tomography (CT) technology for detecting pancreatic injury (PI). This retrospective, multicenter American Association for the Surgery of Trauma-sponsored trial examined the sensitivity of newer 16- and 64-multidetector CT (MDCT) for detecting PI, and sensitivity/specificity for the identification of pancreatic ductal injury (PDI). Patients who received a preoperative 16- or 64-MDCT followed by laparotomy with a documented PI were enrolled. Preoperative MDCT scans were classified as indicating the presence (+) or absence (-) of PI and PDI. Operative notes were reviewed and all patients were confirmed as PI (+), and then classified as PDI (+) or (-). As all patients had PI, an analysis of PI specificity was not possible. PI patients formed the pool for further PDI analysis. As sensitivity and specificity data were available for PDI, multivariate logistic regression was performed for PDI patients using the presence or absence of agreement between CT and operative note findings as an independent variable. Covariates were age, gender, Injury Severity Score, mechanism of injury, presence of oral contrast, presence of other abdominal injuries, performance of the scan as part of a dedicated pancreas protocol, and image thickness < or =3 mm or > or =5 mm. Twenty centers enrolled 206 PI patients, including 71 PDI (+) patients. Intravenous contrast was used in 203 studies; 69 studies used presence of oral contrast. Eight-nine percent were blunt mechanisms, and 96% were able to have their duct status operatively classified as PDI (+) or (-). The sensitivity of 16-MDCT for all PI was 60.1%, whereas 64-MDCT was 47.2%. For PDI, the sensitivities of 16- and 64-MDCT were 54.0% and 52.4%, respectively, with specificities of 94.8% for 16-MDCT scanners and 90.3% for 64-MDCT scanners. Logistic regression showed that no covariates were associated with an increased likelihood of detecting PDI for either 16- or 64-MDCT scanners. The area under the curve was 0.66 for the 16-MDCT PDI analysis and 0.77 for the 64-MDCT PDI analysis. Sixteen and 64-MDCT have low sensitivity for detecting PI and PDI, while exhibiting a high specificity for PDI. Their use as decision-making tools for the nonoperative management of PI are, therefore, limited.

18 May 2009 in Archives of Surgery
Verified
Journal Article
Open access
PDF file
GVGeorge C. Velmahos
George C. Velmahos
MTMalek Tabbara
Malek Tabbara
RGRonald Gross
Ronald Gross
PWPaul Willette
Paul Willette
EHErwin Hirsch
Erwin Hirsch
YCYuchiao Chang
Yuchiao Chang
Despite occurring with low frequency, blunt pancreatoduodenal injuries (BPDIs) are associated with serious complications.1-3 Clinical symptoms and findings from diagnostic tests, including serum amylase levels and computed tomography (CT), are unreliable.4-6 Even after intravenous and oral contrast administration, the sensitivity of CT using early-generation helical scanners ranged from 60% to 70% in most studies.7-9 New technology and protocols have improved the diagnostic ability of CT for various abdominal organ injuries, possibly including BPDI.10

1 March 2008 in Journal of Trauma: Injury, Infection & Critical Care
Verified
Journal Article
Closed access
CSChristian Shults
Christian Shults
ESElizabeth A. Sailhamer
Elizabeth A. Sailhamer
YLYongqing Li
Yongqing Li
BLBaoling Liu
Baoling Liu
MTMalek Tabbara
Malek Tabbara
HAHasan B. Alam
Hasan B. Alam
Patients with massive blood loss often die before delivery of definitive care, especially in austere environments. Strategies that can maintain life during evacuation and transport to higher levels of care may be lifesaving. We have previously shown that administration of histone deacetylase inhibitors (HDACI) enhance gene transcription through specific modifications of DNA-associated histone proteins. Furthermore, it protects against organ damage when given before hemorrhage. The current experiment was done to test whether administration of HDACI after lethal hemorrhage, without fluid resuscitation, would improve outcome by creating a pro-survival phenotype. Seventy-two male Wistar-Kyoto rats (n = 12 per group) were subjected to 60% blood volume loss for 1 hour (40% arterial bleed for 10 minutes and 20% venous bleed for 50 minutes). After hemorrhage, animals were randomized to receive one of two HDACI: (1) valproic acid (VPA, 300 mg/kg in 0.25 mL saline), or (2) suberoyanilide hydroxamic acid (SAHA, 7.5 mg/kg in 0.25 mL saline). Control groups included (3) no hemorrhage (Sham), (4) no resuscitation (NR), (5) 0.9% saline resuscitation, 3 times the volume of shed blood (NS), and (6) vehicle control, 0.25 mL 0.9% saline (VEH). Hemodynamic data were recorded continuously, and physiologic parameters were measured serially. Survival for 3 hours was the primary endpoint for this experiment. Nonresuscitated shock (NR group) was highly lethal and only 25% of the animals survived for 3 hours. Administration of HDACI after hemorrhage (without fluid resuscitation) significantly improved survival (75% and 83% in VPA and SAHA groups, respectively, p < 0.05 vs. NR). Survival was 40%, 100%, and 100% in the VEH, Sham, and NS resuscitation groups, respectively. This study demonstrates that post-shock administration of HDACI can significantly improve early survival in a highly lethal model of hemorrhagic shock, even in the absence of conventional fluid resuscitation. This approach may be especially relevant for austere environments where fluids are in limited supply, such as a battlefield.